Insider · CIK 0001875324
Carolyn E. Taylor
Files at TNXP (Tonix Pharmaceuticals Holding Corp.). First filing Aug 21, 2025, latest Jun 15, 2026.
In brief
Carolyn E. Taylor files SEC Form 4 as director at TNXP (Tonix Pharmaceuticals Holding Corp.). Since Aug 21, 2025, Carolyn E. Taylor has reported 2 open-market buys worth $30k and 0 open-market sells worth $0, the latest filed on Jun 15, 2026.
A track record needs three past buys with six months of prices behind them; Carolyn E. Taylor has 1, so none is measured yet.
The newest scored trade: bought $15k of TNXP on Jun 12, 2026, filed Jun 15, 2026, scored 58 (moderate). In the last 12 months: 1 buy worth $15k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
TNXP: Tonix Pharmaceuticals Holding Corp.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 58Moderate | Tonix Pharmaceuticals Holding Corp. | $15k 1,415 shares | +339% | +7% from low-82% from high | |
| 31Weak | Tonix Pharmaceuticals Holding Corp. | $15k 418 shares | - | - |
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 12, 2026 | TNXP Tonix Pharmaceuticals Holding Corp. | POpen-market purchase Common Stock, $0.001 par value | +1,415 | $10.55 | $15k | 1,833 | Jun 15, 2026 |
| May 12, 2026 | TNXP Tonix Pharmaceuticals Holding Corp. | AGrant or award Stock Optionderivative | +22,700 | $0.00 | $0 | 22,700 | May 14, 2026 |
| Aug 21, 2025 | TNXP Tonix Pharmaceuticals Holding Corp. | POpen-market purchase Common Stock, par value $0.001 | +418 | $36.03 | $15k | 418 | Aug 21, 2025 |
| May 13, 2025 | TNXP Tonix Pharmaceuticals Holding Corp. | AGrant or award Stock Optionderivative | +10,000 | $0.00 | $0 | 10,000 | May 15, 2025 |
Questions about Carolyn E. Taylor
Answered from the filings on this page, as of the latest one.
Is Carolyn E. Taylor buying or selling?
In the last 12 months Carolyn E. Taylor reported 1 open-market buy worth $15k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $15k of TNXP on Jun 12, 2026. Grants, option exercises and tax withholding are not counted.
How did Carolyn E. Taylor's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Carolyn E. Taylor has 1.
Where does Carolyn E. Taylor file Form 4?
Carolyn E. Taylor has filed Form 4 at TNXP (Tonix Pharmaceuticals Holding Corp.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.